Stock Ratings / Health Care / RVTY / insiders

AVTR (59) TXG (65) BIO (66) MTD (77) ⌘ Pro Terminal →

Revvity Inc. (RVTY) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$165.78 +0.27% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Revvity Inc. (RVTY) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $18.50B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C+

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C+ · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+4.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for RVTY)Realized 20D OHLCV Swing Band: ±8.1%

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

RVTY Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (RVTY)

No recent open-market Form 4 cluster sales or emergency dumps flagged on RVTY. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (RVTY Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 1,540+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

RVTY // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +91.63%▲ ASCENDING CHANNEL

2026-11-01O $165.3H $165.8L $165.3C $165.8VOL 1.53M

RES: $179.3SUP: $139.9SMA50: $145.3SMA200: $112.1

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

RVTY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 RVTY Butterfly Map → + Track RVTY →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. +3.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on RVTY today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for RVTY. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for RVTY today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (RVTY)

Health Care Rank #72 of 188 ⚔️ AVTR vs RVTY Full Matrix →

1. Head-to-Head Health Care Peer Comparison (RVTY vs. AVTR, TXG, BIO, MTD)

Industry: Biotechnology: Laboratory Analytical Instruments (8 Tracked Issuers)

Across 188 tracked Health Care securities in the Roarable RQD universe, Revvity Inc. (RVTY) ranks #72 by composite RQD confidence (68/100, grade C+) and #74 by equity capitalization ($18.50B). Within this direct 5-issuer industry benchmark cohort, BIO leads on earnings valuation at 13.5x trailing P/E, while MTD leads on capital efficiency and profitability with 30.4% ROIC and 59.4% gross margin. MTD currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with RVTY at 68/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
RVTY ACTIVE Revvity Inc.	C+	68/100	76.7x	—	3.1%	+0.27%	$18.50B	Benchmark Subject
AVTR Avantor Inc.	C-	59/100	—	32.7%	-2.1%	-0.06%	$11.30B	/avtr-vs-rvty →
TXG 10x Genomics Inc.	C	65/100	—	69.1%	-5.7%	-2.47%	$10.63B	/txg-vs-rvty →
BIO Bio-Rad Laboratories Inc.	C+	66/100	13.5x	51.9%	0.5%	-0.19%	$10.28B	/bio-vs-rvty →
MTD Mettler-Toledo International Inc.	B+	77/100	39.6x	59.4%	30.4%	+1.19%	$34.44B	/mtd-vs-rvty →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-28 • CIK 0000031791

In its most recent audited fiscal period (FY2025, filed 2025-12-28), Revvity Inc. (RVTY) reported GAAP revenue of $2.86B (+3.7% vs. FY2024 revenue of $2.76B , and +3.8% cumulative change since FY2023) , GAAP net income of $241.2M, operating cash flow of $582.9M, and free cash flow of $509.4M (-6.0% YoY). On the balance sheet, RVTY closed FY2025 with $12.17B in total assets against $2.63B in total debt (Altman Z-Score: 3.37, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-28	$2.86B	$241.2M	$582.9M	$509.4M	$12.17B	$2.63B
FY2024 (FY)	2024-12-29	$2.76B	$270.4M	$628.3M	$541.7M	$12.39B	$3.15B
FY2023 (FY)	2023-12-31	$2.75B	$693.1M	$91.3M	-$32.5M	$10.17B	$2.38B

3. RVTY Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is RVTY stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Revvity Inc. (NYSE: RVTY) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $165.78 (+0.27% 1D, market cap $18.50B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 19/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 9/20. Across 188 tracked Health Care issuers, RVTY ranks #72 in composite RQD confidence.

How does RVTY compare to AVTR and TXG in the Health Care sector?

Within the Health Care sector (Biotechnology: Laboratory Analytical Instruments), RVTY carries a Roarable C+ (68/100 RQD), trailing P/E of 76.7x, gross margin of —, and ROIC of 3.1%. By comparison, AVTR (Avantor Inc.) holds a C- grade (59/100 RQD, P/E N/A, ROIC -2.1%, cap $11.30B) and TXG (10x Genomics Inc.) posts a C grade (65/100 RQD, P/E N/A, ROIC -5.7%, cap $10.63B). Among the 5-stock peer group, BIO leads on earnings multiple (13.5x) while MTD leads on capital efficiency (30.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for RVTY?

Per RVTY's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-28, CIK 0000031791), Revvity Inc. generated $2.86B in revenue (+3.7% YoY), $241.2M in net income, and $509.4M in free cash flow against $12.17B in total assets and $2.63B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is RVTY trading relative to its 50-day, 200-day, and 52-week technical levels?

RVTY last traded at $165.78 (+0.27% on volume of 1,530,048 shares), positioning the stock +14.09% above its 50-day simple moving average ($145.30) and +47.85% above its 200-day simple moving average ($112.13). Across its 52-week range of $81.22 to $169.06, RVTY sits at the 96.3% percentile with a 14-day RSI of 64.5 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.1% ($152.35 to $179.21).

RVTY Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are RVTY insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies RVTY leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.

Direct Sub-Reports: RVTY RQD Cockpit RVTY 12M Forecast RVTY Earnings & Move RVTY Dividends & DRIP RVTY Insiders & 13F RVTY Whale Options RVTY Profit Sankey RVTY News & Why